Lenacapavir HIV Prevention: Gilead’s Stra...

By João L. Carapinha

July 10, 2025

Gilead Sciences has finalized a strategic partnership with the Global Fund. The agreement aims to supply lenacapavir HIV prevention, a twice-yearly inject...
Revolutionizing Pediatric Care: Approval of Malaria Medicine for Newborns
10-Year Health Plan: Transforming England’s NHS for the Future
Dutch Health Disruption: Reimagining Care with Social Entrepreneurship
Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
What are the Plans and Implications for Keytruda´s Biosimilar
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
South Africa NHI Bill Court Ruling Calls for Scrutiny
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy